Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,032.50    -10.00 (-0.96%)
Bid:
1,033.50
Ask:
1,035.00
Spread: 1.50 (0.145%)
Market Cap: £5.05b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading Update

25 Sep 2019 07:00

RNS Number : 5383N
Babcock International Group PLC
25 September 2019
 

25 September 2019

Babcock International Group PLC (Babcock or the Group)

Babcock, the aerospace and defence company, is issuing the following trading update for the period from 1 April 2019.

Trading update

Trading across the Group is in line with our expectations.

 

Our Marine sector is performing well with increased activity across our UK warship support business and strong orders across our technology businesses. The Queen Elizabeth Class (QEC) programme is nearing completion with HMS Prince of Wales leaving Rosyth for sea trials while our Type 23 frigate life extension programme continues to progress. In Australia and Canada we continued to make good progress on our submarine and surface ship sustainment programmes. In Land, we are continuing to make good progress across our Defence Support Group (DSG) business and have successfully transitioned to the new CP6 contract in Rail. We have also seen an improvement in our South African business.

 

In Nuclear, activity levels have increased across defence though the civil nuclear market remains challenging. As expected, the Magnox contract transitioned to the Nuclear Decommissioning Authority at the end of August. In Aviation, we saw the successful start of our new international businesses in Canada and Norway and have made continued progress across our military businesses. While we have seen some delays in the award of new contracts in Aviation, overall bidding activity across the sector has increased.

 

Contract awards

The Group continued to win work across all sectors in the period, with win rates in line with our targets.

 

The highlight in the period was our selection as the preferred bidder for the Type 31 general-purpose frigate programme, which will provide the UK with a fleet of five new warships for £1.25 billion. The ships will be assembled at Babcock's Rosyth facility, and involve supply chains throughout the UK. Work will begin immediately following formal contract award later this financial year, with detailed design work to start now and manufacture commencing in 2021 and concluding in 2027.

 

Expectations for the year

We confirm our full year guidance for revenue, operating profit and free cash flow as set out in May 2019, including the phasing between the first and second halves of the year, especially for cash generation. We expect the first half to reflect the phasing of previously communicated step downs1, the normal seasonality of our business and last year's phasing of Fomedec equipment sales in our Aviation business.

 

Refinancing completed

During the period, both Standard & Poor's and DBRS confirmed the Group's credit rating of BBB following their annual credit reviews. We renewed our 5-year Revolving Credit Facility of up to £775 million and issued €550 million (c.£500 million) of 8-year bonds expiring in 2027.

 

As already announced, the estimated impact of this is to increase finance costs by around £5 million in FY20 and around £7 million in FY21 and reduce finance costs by around £2 million each year in the years following.

 

ends

 

 

For further information please contact:

Babcock International Group PLC

Simon McGough

Kate Hill

Director of Investor Relations

Group Director of Communications

Tel: +44 (0)20 3823 5592

Tel: +44 (0)20 7355 5312

FTI Consulting

Andrew Lorenz, Nick Hasell

Tel: +44 (0)20 3727 1340

 

 

Conference call

A conference call for analysts and investors will be held at 08:00 (UK time) this morning, hosted by Archie Bethel (Chief Executive) and Franco Martinelli (Group Finance Director).

 

Webcast link:

www.babcockinternational.com/investors/results-and-presentations 

 

Live call:

Standard International Access

+44 (0) 20 3003 2666

UK Toll Free

0808 109 0700

Replay (available for 7 days):

Standard International Access

+44 (0) 20 8196 1480

UK Toll Free

0800 633 8453

PIN

4072877#

 

A transcript will be made available at www.babcockinternational.com/investors.

 

 

Notes

1. As stated in May 2019:

a. Revenue step downs for the full year of £410 million (QEC £80 million, Magnox £256 million, exit and disposals £74 million). The first half impact is expected to be around £150 million.

b. Operating profit step downs for the full year of £63 million (QEC £2 million, Magnox £24 million, Holdfast £17 million, exits and disposals £10 million and Brexit-related Aviation restructuring costs of £10 million). The first half impact is expected to be around £35 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEMFALFUSEEU
Date   Source Headline
6th Oct 20172:42 pmRNSAnna Stewart
20th Sep 20179:51 amRNSHolding(s) in Company
20th Sep 20177:00 amRNSTrading Update
8th Sep 201710:41 amRNSPublication of a Prospectus
17th Aug 201711:37 amRNSHolding(s) in Company
16th Aug 201711:54 amRNSDirector/PDMR Shareholding
13th Jul 20173:48 pmRNSResult of AGM
13th Jul 20177:00 amRNSAnnual General Meeting Trading Update
29th Jun 20177:00 amRNSContract Award
27th Jun 201712:32 pmRNSDirector/PDMR Shareholding
22nd Jun 201712:00 pmRNSDirector/PDMR Shareholding
20th Jun 201711:53 amRNSDirector/PDMR Shareholding
19th Jun 201710:53 amRNSDirector/PDMR Shareholding
15th Jun 20173:58 pmRNSDirector/PDMR Shareholding
13th Jun 20175:08 pmRNSNotice of AGM
7th Jun 20175:24 pmRNSHolding(s) in Company
7th Jun 20174:55 pmRNSDirector/PDMR Shareholding
7th Jun 20171:17 pmRNSDirector/PDMR Shareholding
1st Jun 201710:11 amRNSPublication of Final Terms
30th May 20175:23 pmRNSDirector/PDMR Shareholding
24th May 20173:43 pmRNSHolding(s) in Company
24th May 20177:00 amRNSFinal Results
19th May 20179:34 amRNSHolding(s) in Company
2nd May 20179:59 amRNSHolding(s) in Company
13th Apr 201710:09 amRNSHolding(s) in Company
13th Apr 20178:55 amRNSHolding(s) in Company
11th Apr 20179:26 amRNSHolding(s) in Company
3rd Apr 20177:00 amRNSPreferred bidder for Royal Navy support contract
29th Mar 20174:38 pmRNSHolding(s) in Company
27th Mar 20173:01 pmRNSDirector/PDMR Shareholding
27th Mar 20172:58 pmRNSDirector/PDMR Shareholding
27th Mar 201712:10 pmRNSDirector/PDMR Shareholding
27th Mar 20177:22 amRNSMagnox decommissioning contract
24th Mar 20179:54 amRNSHolding(s) in Company
14th Mar 20177:00 amRNSRealignment Presentation
28th Feb 20177:00 amRNSTrading Update
24th Feb 20171:00 pmRNSHolding(s) in Company
15th Feb 201712:11 pmRNSHolding(s) in Company
9th Feb 20174:53 pmRNSHolding(s) in Company
7th Feb 20175:00 pmRNSDirector Declaration
3rd Feb 20175:23 pmRNSHolding(s) in Company
20th Jan 201710:01 amRNSDirector/PDMR Shareholding
5th Jan 20179:00 amRNSFOMEDEC Contract Award
12th Dec 20161:19 pmRNSDirector Declaration
28th Nov 20164:18 pmRNSHolding(s) in Company
28th Nov 201611:07 amRNSDirector/PDMR Shareholding
23rd Nov 20163:48 pmRNSHolding(s) in Company
23rd Nov 20162:56 pmRNSHolding(s) in Company
22nd Nov 20167:00 amRNSHalf-year Report
21st Nov 201611:13 amRNSContract Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.